ESTRELLA IMMUNOPHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $0 | $478.9K |
| FY2022 | — | $-1.0M | $4.1M |
| FY2023 | — | $-11.7M | $2.5M |
| FY2024 | — | $4.3M | $4.2M |
| FY2025 | — | $-10.4M | $1.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $0 | $478.9K |
| FY2022 | — | $-1.0M | $4.1M |
| FY2023 | — | $-11.7M | $2.5M |
| FY2024 | — | $4.3M | $4.2M |
| FY2025 | — | $-10.4M | $1.4M |